Lenalidomide Improves Cognitive Function and Reduces Immune Reconstitution Inflammatory Syndrome in HIV-1-Related Cryptococcal Meningitis

References

• Balasko A, Keynan Y. Shedding light on IRIS: from pathophysiology to treatment of cryptococcal meningitis and immune reconstitution inflammatory syndrome in HIV-infected individuals. HIV Med. 2019;20(1):1–10. doi:10.1111/hiv.12676
   PubMed Web of Science ®Google Scholar
• Elsegeiny W, Marr KA, Williamson PR. Immunology of cryptococcal infections: developing a rational approach to patient therapy. Front Immunol. 2018;9:651. doi:10.3389/fimmu.2018.00651
   PubMed Web of Science ®Google Scholar
• Steff M, Joly V, Di Lucca J, et al. Clinical activity of Lenalidomide in visceral human immunodeficiency virus–related Kaposi sarcoma. JAMA Dermatol. 2013;149(11):1319–1322. doi:10.1001/jamadermatol.2013.5751
   PubMed Web of Science ®Google Scholar
• Bibas M, Grisetti S, Alba L, Picchi G, Del Nonno F, Antinori A. Patient with HIV-associated plasmablastic lymphoma responding to bortezomib alone and in combination with dexamethasone, gemcitabine, oxaliplatin, cytarabine, and pegfilgrastim chemotherapy and lenalidomide alone. J Clin Oncol. 2010;28(34):e704–e708. doi:10.1200/JCO.2010.30.0038
   PubMed Web of Science ®Google Scholar
• Denman J, Manavi K, Cook M. Lenalidomide as a treatment for relapsed AL amyloidosis in an HIV-positive patient. Int J STD AIDS. 2017;28(10):1045–1047. doi:10.1177/0956462417694561
   PubMed Web of Science ®Google Scholar
• Nasreddine ZS, Phillips NA, Bédirian V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695–699. doi:10.1111/j.1532-5415.2005.53221.x
   PubMed Web of Science ®Google Scholar
• Sacktor NC, Wong M, Nakasujja N, et al. The International HIV Dementia Scale: a new rapid screening test for HIV dementia. AIDS. 2005;19(13):1367–1374.
   PubMed Web of Science ®Google Scholar
• Sitapati AM, Kao CL, Cachay ER, Masoumi H, Wallis RS, Mathews WC. Treatment of HIV-related inflammatory cerebral cryptococcoma with Adalimumab. Clin Infect Dis. 2010;50(2):e7–e10. doi:10.1086/649553
   PubMed Web of Science ®Google Scholar
• Brunel AS, Reynes J, Tuaillon E, et al. Thalidomide for steroid-dependent immune reconstitution inflammatory syndromes during AIDS. AIDS. 2012;26(16):2110–2112. doi:10.1097/QAD.0b013e328358daea
   PubMed Web of Science ®Google Scholar
• Heaton RK, Clifford DB, Franklin DR, et al. HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology. 2010;75(23):2087–2096. doi:10.1212/WNL.0b013e318200d727
   PubMed Web of Science ®Google Scholar
• Habib AG, Yakasai AM, Owolabi LF, et al. Neurocognitive impairment in HIV-1-infected adults in Sub-Saharan Africa: a systematic review and meta-analysis. Int J Infect Dis. 2013;17(10):e820–e831. doi:10.1016/j.ijid.2013.06.011
   PubMed Web of Science ®Google Scholar
• Saylor D. Neurologic complications of human immunodeficiency virus infection. Continuum. 2018;24(5):1397–1421. doi:10.1212/CON.0000000000000647
   PubMedGoogle Scholar
• Sutherland EJ, Brew BJ. Human immunodeficiency virus and the nervous system. Neurol Clin. 2018;36(4):751–765. doi:10.1016/j.ncl.2018.07.002
   PubMed Web of Science ®Google Scholar
• Levine AJ, Hinkin CH, Ando K, et al. An exploratory study of long-term neurocognitive outcomes following recovery from opportunistic brain infections in HIV+ adults. J Clin Exp Neuropsychol. 2008;30(7):836–843. doi:10.1080/13803390701819036
   PubMed Web of Science ®Google Scholar
• Haddow LJ, Colebunders R, Meintjes G, et al. Cryptococcal immune reconstitution inflammatory syndrome in HIV-1-infected individuals: proposed clinical case definitions. Lancet Infect Dis. 2010;10(11):791–802. doi:10.1016/S1473-3099(10)70170-5
   PubMed Web of Science ®Google Scholar
• Müller M, Wandel S, Colebunders R, et al. Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis. Lancet Infect Dis. 2010;10(4):251–261. doi:10.1016/S1473-3099(10)70026-8
   PubMed Web of Science ®Google Scholar
• Lawn SD, Bekker LG, Myer L, Orrell C, Wood R. Cryptococcocal immune reconstitution disease: a major cause of early mortality in a South African antiretroviral programme. AIDS. 2005;19(17):2050–2052. doi:10.1097/01.aids.0000191232.16111.f9
   PubMed Web of Science ®Google Scholar
• Vlasova-St Louis I, Chang CC, Shahid S, French MA, Bohjanen PR. Transcriptomic predictors of paradoxical cryptococcosis-associated immune reconstitution inflammatory syndrome. Open Forum Infect Dis. 2018;5(7):ofy157. doi:10.1093/ofid/ofy157
   PubMed Web of Science ®Google Scholar
• Jenny-Avital ER, Abadi M. Immune reconstitution cryptococcosis after initiation of successful highly active antiretroviral therapy. Clin Infect Dis. 2002;35(12):e128–e133. doi:10.1086/344467
   PubMed Web of Science ®Google Scholar
• Lortholary O, Fontanet A, Mémain N, et al. Incidence and risk factors of immune reconstitution inflammatory syndrome complicating HIV-associated cryptococcosis in France. AIDS. 2005;19(10):1043–1049. doi:10.1097/01.aids.0000174450.70874.30
   PubMed Web of Science ®Google Scholar
• Beardsley J, Hoang NLT, Kibengo FM, et al. Do intracerebral cytokine responses explain the harmful effects of dexamethasone in human immunodeficiency virus-associated cryptococcal meningitis? Clin Infect Dis. 2019;68(9):1494–1501. doi:10.1093/cid/ciy725
   PubMed Web of Science ®Google Scholar
• Martinez FO, Gordon S. The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000Prime Rep. 2014;6:13. doi:10.12703/P6-13
   PubMedGoogle Scholar
• Boulware DR, Meya DB, Bergemann TL, et al. Clinical features and serum biomarkers in HIV immune reconstitution inflammatory syndrome after cryptococcal meningitis: a prospective cohort study. PLoS Med. 2010;7(12):e1000384. doi:10.1371/journal.pmed.1000384
   PubMed Web of Science ®Google Scholar
• Dellière S, Guery R, Candon S, et al. Understanding pathogenesis and care challenges of immune reconstitution inflammatory syndrome in fungal infections. J Fungi. 2018;4(4):139. doi:10.3390/jof4040139
   Web of Science ®Google Scholar
• Muller GW, Chen R, Huang SY, et al. Amino-substituted thalidomide analogs: potent inhibitors of TNF-alpha production. Bioorg Med Chem Lett. 1999;9(11):1625–1630. doi:10.1016/S0960-894X(99)00250-4
   PubMed Web of Science ®Google Scholar
• Kumar S, Rajkumar SV. Thalidomide and lenalidomide in the treatment of multiple myeloma. Eur J Cancer. 2006;42(11):1612–1622. doi:10.1016/j.ejca.2006.04.004
   PubMed Web of Science ®Google Scholar
• Okafor EC, Hullsiek KH, Williams DA, et al. Correlation between blood and CSF compartment cytokines and chemokines in subjects with cryptococcal meningitis. Mediators Inflamm. 2020;2020:8818044. doi:10.1155/2020/8818044
   PubMed Web of Science ®Google Scholar
• Lee YP, Hong JY, Yoon SE, et al. Real-world, single-center data for lenalidomide plus rituximab in relapsed or refractory diffuse large B-cell lymphoma and transformed follicular lymphoma. Cancer Manag Res. 2021;13:4241–4250. doi:10.2147/CMAR.S309092
   PubMed Web of Science ®Google Scholar
• Goldfinger M, Xu M, Bertino JR, Cooper DL. Checking in on lenalidomide in diffuse large B cell lymphoma. Clin Lymphoma Myeloma Leuk. 2019;19(6):e307–e311. doi:10.1016/j.clml.2019.02.012
   PubMed Web of Science ®Google Scholar
• Almeida F, Macedo A, Trigo D, et al. Neurocognitive evaluation using the International HIV Dementia Scale (IHDS) and Montreal Cognitive Assessment Test (MoCA) in an HIV 2 population. HIV Med. 2021;22(3):212–217. doi:10.1111/hiv.12963
   PubMed Web of Science ®Google Scholar
• Aita SL, Kaewpoowat Q, Yasri S, et al. Psychometric utility of the international HIV dementia scale and Montreal Cognitive Assessment in HIV-associated asymptomatic neurocognitive impairment. J Neurovirol. 2021;27(4):568–578. doi:10.1007/s13365-021-00991-z
   PubMed Web of Science ®Google Scholar